JP2019535707A5 - - Google Patents

Download PDF

Info

Publication number
JP2019535707A5
JP2019535707A5 JP2019524328A JP2019524328A JP2019535707A5 JP 2019535707 A5 JP2019535707 A5 JP 2019535707A5 JP 2019524328 A JP2019524328 A JP 2019524328A JP 2019524328 A JP2019524328 A JP 2019524328A JP 2019535707 A5 JP2019535707 A5 JP 2019535707A5
Authority
JP
Japan
Prior art keywords
polypeptide
composition according
composition
arthritis
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2019524328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019535707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/057081 external-priority patent/WO2018087727A1/en
Publication of JP2019535707A publication Critical patent/JP2019535707A/ja
Publication of JP2019535707A5 publication Critical patent/JP2019535707A5/ja
Priority to JP2022193539A priority Critical patent/JP2023039962A/ja
Withdrawn legal-status Critical Current

Links

JP2019524328A 2016-11-14 2017-11-13 軟骨損傷および関節炎の処置のための方法および組成物 Withdrawn JP2019535707A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022193539A JP2023039962A (ja) 2016-11-14 2022-12-02 軟骨損傷および関節炎の処置のための方法および組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662421534P 2016-11-14 2016-11-14
US62/421,534 2016-11-14
US201762560301P 2017-09-19 2017-09-19
US62/560,301 2017-09-19
PCT/IB2017/057081 WO2018087727A1 (en) 2016-11-14 2017-11-13 Methods and compositions for treatment of cartilage damage and arthritis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022193539A Division JP2023039962A (ja) 2016-11-14 2022-12-02 軟骨損傷および関節炎の処置のための方法および組成物

Publications (2)

Publication Number Publication Date
JP2019535707A JP2019535707A (ja) 2019-12-12
JP2019535707A5 true JP2019535707A5 (enExample) 2020-12-24

Family

ID=60629753

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019524328A Withdrawn JP2019535707A (ja) 2016-11-14 2017-11-13 軟骨損傷および関節炎の処置のための方法および組成物
JP2022193539A Pending JP2023039962A (ja) 2016-11-14 2022-12-02 軟骨損傷および関節炎の処置のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022193539A Pending JP2023039962A (ja) 2016-11-14 2022-12-02 軟骨損傷および関節炎の処置のための方法および組成物

Country Status (10)

Country Link
US (3) US11351223B2 (enExample)
EP (1) EP3538127A1 (enExample)
JP (2) JP2019535707A (enExample)
KR (2) KR20240045351A (enExample)
CN (2) CN109963579A (enExample)
AU (2) AU2017357785A1 (enExample)
CA (1) CA3043667A1 (enExample)
IL (1) IL266361B2 (enExample)
MX (2) MX2019005621A (enExample)
WO (1) WO2018087727A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117355323A (zh) 2021-05-24 2024-01-05 诺华股份有限公司 用于治疗骨关节炎的方法
TW202306970A (zh) 2021-05-24 2023-02-16 瑞士商諾華公司 用於治療骨關節炎之方法
WO2023084388A1 (en) * 2021-11-10 2023-05-19 Novartis Ag Methods for determining the biological activity of angptl polypeptides

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2464532T3 (es) 2001-04-19 2014-06-03 The Scripps Research Institute Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa
MXPA05003983A (es) 2002-10-16 2005-06-22 Scripps Research Inst Incorporacion en sitio especifico de cetoaminoacidos en proteinas.
EP1558747B1 (en) 2002-10-16 2009-10-14 The Scripps Research Institute Glycoprotein synthesis
JP5642916B2 (ja) 2003-04-17 2014-12-17 ザ スクリプス リサーチ インスティテュート 真核遺伝コードの拡張
WO2005019415A2 (en) 2003-07-07 2005-03-03 The Scripps Research Institute Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof
EP1704242A4 (en) 2003-07-07 2008-06-18 Scripps Research Inst COMPOSITIONS WITH PAIRS OF ORTHOGONAL LEUCYL-TRNA AND AMINOACYL-TRNA-SYNTHETASE AND USES THEREOF
WO2005007624A2 (en) 2003-07-07 2005-01-27 The Scripps Research Institute Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof
MX2007003142A (es) 2004-09-21 2007-07-04 Scripps Research Inst Incorporacion in vivo de alquinil aminoacidos a proteinas en eubacterias.
MX2007004892A (es) 2004-10-27 2007-08-16 Scripps Research Inst Componentes de traduccion ortogonales para la incorporacion in vivo de aminoacidos no naturales.
MX2008011470A (es) 2006-03-09 2008-09-24 Scripps Research Inst Sistemas para la expresion de componentes de traduccion ortogonales en celulas huesped eubacterianas.
EP2118150B1 (en) 2007-02-14 2015-09-23 Biocompatibles UK Limited Derivatisation of biological molecules
CA2746395C (en) * 2008-12-10 2019-07-09 Ablynx N.V. Polypeptides comprising amino acid sequences directed against tie 2 for the treatment of diseases and disorders related to angiogenesis
PE20160507A1 (es) * 2009-07-14 2016-05-20 Scripps Research Inst Diferenciacion de celulas madre mesenquimales
UY32979A (es) * 2009-10-28 2011-02-28 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
AU2013204754C1 (en) * 2012-05-16 2018-10-11 Takeda Pharmaceutical Company Limited Nucleophilic Catalysts for Oxime Linkage
US9301971B2 (en) * 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
UY35368A (es) * 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
EP2968330B1 (en) * 2013-03-15 2021-09-29 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
HRP20241236T1 (hr) * 2014-05-13 2024-12-06 Novartis Ag Spojevi i pripravci za induciranje hondrogeneze

Similar Documents

Publication Publication Date Title
CL2020000252A1 (es) Muteínas de interleucina 21 y métodos de tratamiento.
JP2016510763A5 (enExample)
JP2018522563A5 (enExample)
MX2020004969A (es) Composiciones y procedimientos para tratar cancer.
JP2015522576A5 (enExample)
JP2017528444A5 (enExample)
JP2018520090A5 (enExample)
RU2011122201A (ru) Связывающие белки, ингибирующие взаимодействия vegf-a рецептора
JP2019517790A5 (enExample)
JP2017518303A5 (enExample)
AR065289A1 (es) Antagonistas de activina - actriia y sus usos para la promocion del crecimiento oseo y el tratamiento de mieloma multiple
JP2014169326A5 (enExample)
JP2016516722A5 (enExample)
JPWO2019156137A5 (enExample)
Evans et al. Orthopaedic gene therapy: Twenty-five years on
JP2017504589A5 (enExample)
PH12019502522A1 (en) Oncolytic virus and method
US20210052776A1 (en) Mesenchymal stem cells or stromal cells harboring modified rnas encoding vegf and bmp polypeptides
JP2012517482A5 (enExample)
RU2017128296A (ru) Композиция для лечения бесплодия
JP2006506942A5 (enExample)
RU2016152151A (ru) Препарат, содержащий фактор viii и пептиды фактора фон виллебранда
JP2024543209A5 (enExample)
RU2016107873A (ru) Пептиды
RU2014124030A (ru) Применение фрагментов гормона роста